Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Restasis for Docetaxel-Induced Epiphora
NCT00824811Phase 2Withdrawn
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Jun 2009
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of cyclosporine 2% ophthalmic solution in epiphora, sponsored by University of Texas MD Anderson Cancer Center. Planned start Jun 2009; status: withdrawn.
02
Drugs
cyclosporine 2% ophthalmic solution
03
Conditions
epiphora
Beyond the preview
Go deeper on NCT00824811.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00824811.